Your browser doesn't support javascript.
loading
Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results.
Cortes, Jorge E; Douglas Smith, B; Wang, Eunice S; Merchant, Akil; Oehler, Vivian G; Arellano, Martha; DeAngelo, Daniel J; Pollyea, Daniel A; Sekeres, Mikkael A; Robak, Tadeusz; Ma, Weidong Wendy; Zeremski, Mirjana; Naveed Shaik, M; Douglas Laird, A; O'Connell, Ashleigh; Chan, Geoffrey; Schroeder, Mark A.
Affiliation
  • Cortes JE; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, Texas.
  • Douglas Smith B; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
  • Wang ES; Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Merchant A; Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Oehler VG; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Arellano M; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.
  • DeAngelo DJ; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Pollyea DA; Division of Hematology, University of Colorado School of Medicine, Aurora, Colorado.
  • Sekeres MA; Leukemia Program, Cleveland Clinic, Cleveland, Ohio.
  • Robak T; Department of Hematology, Medical University of Lodz, Lodz, Poland.
  • Ma WW; Pfizer Oncology, New York, New York.
  • Zeremski M; Pfizer Oncology, New York, New York.
  • Naveed Shaik M; Pfizer Oncology, New York, New York.
  • Douglas Laird A; Pfizer Oncology, New York, New York.
  • O'Connell A; Pfizer Oncology, New York, New York.
  • Chan G; Pfizer Oncology, New York, New York.
  • Schroeder MA; Division of Oncology, Washington University School of Medicine, St Louis, Missouri.
Am J Hematol ; 93(11): 1301-1310, 2018 11.
Article in En | MEDLINE | ID: mdl-30074259

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Benzimidazoles / Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2018 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Benzimidazoles / Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2018 Type: Article